Aim: To determine the effect of anticoagulants and antiplatelet medications on the positive-predictive-value of fecal occult blood test (FOBT).
Methods: All patients who underwent a colonoscopy at our institution from 1995 to 2006 for a positive FOBT were identified. Medical records were searched, and patients were stratified into five groups selected a priori: low-dose aspirin, NSAIDs, warfarin, clopidogrel, or controls. The positive-predictive-value of FOBT for advanced colonic neoplasia was computed for each group.
Results: During the study period, 1,126 patients underwent colonoscopy for a positive FOBT and met entry criteria. The average age of study participants was 69 years and most were men. The positive-predictive-value of FOBT for advanced colon neoplasia was significantly higher in the control group (30.5%) when compared to those on low-dose aspirin (20.5%; p = 0.003), NSAIDs (19.7%; p = 0.003), clopidogrel (7.3%; p = 0.002), or warfarin (20%; p = 0.05). The positive-predictive-value of FOBT was significantly lower for those on clopidogrel than those on low-dose aspirin (p = 0.04) and NSAIDs (p = 0.05), but not warfarin (p = 0.08). The positive-predictive-value for FOBT was similar for those on aspirin, NSAIDs, and warfarin. There was a linear trend between the number of number of positive FOBT cards and prevalence of advanced colon neoplasia (p = 0.01).
Conclusion: Anticoagulants and antiplatelet medications lower the positive-predictive-value of FOBT for advance colonic neoplasia and should be stopped if clinically feasible prior to stool collection.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10620-010-1150-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Development and Validation of a Colorectal Cancer Prediction Model: A Nationwide Cohort-Based Study.
Dig Dis Sci
July 2024
Innovation Division, Clalit Research Institute, Clalit Health Services, Tel Aviv, Israel.
Article Synopsis
- Early detection of colorectal cancer (CRC) is essential for improving survival rates, and risk prediction models can help spot individuals at higher risk using health records.
- The study analyzed EHR data from Clalit Health Services, involving over 1.1 million people aged 50-74, to develop a model predicting CRC diagnosis within two years, which considered around 20,000 clinical features.
- The results indicated that the model effectively identified high-risk individuals, with those in the top 1% risk scores showing significantly higher CRC incidence, making it a valuable tool for healthcare providers to target at-risk patients for further testing.
National cancer screening program for colorectal cancer in Korea.
Ann Surg Treat Res
December 2023
Division of Colorectal Surgery, Department of Surgery, Ewha Womans University College of Medicine, Seoul, Korea.
Article Synopsis
- * The study evaluates the National Cancer Screening Program, highlighting the switch from fecal occult blood tests (FOBT) to fecal immunochemical tests (FIT) for better screening effectiveness.
- * Despite a stable screening rate, there is potential for improvement, and it may be time to update screening guidelines to cater to Korea’s aging population.
Positive Fecal Occult Blood Test and Colonoscopy With Histopathology Findings in Saudi Adults.
Cureus
August 2023
College of Medicine, Imam Mohammed bin Saud Islamic University, Riyadh, SAU.
Background/aims Colorectal cancer cases are on the rise in developing countries, necessitating dependable detection tests. Moreover, medical procedures have become increasingly burdensome for both patients and healthcare professionals. This study aims to delve deeper into the fecal occult blood test (FOBT) as a potential solution.
View Article and Find Full Text PDFLow potency of fecal immunological surveillance testing soon after negative colonoscopy or resection of low-risk adenoma in average-risk patients.
Eur J Gastroenterol Hepatol
December 2021
Department of Internal Medicine 2, Shimane University School of Medicine, Izumo, Japan.
Background: Postcolonoscopy surveillance colonoscopy based on positive fecal occult blood testing (FOBT) is often performed, although its long-term efficacy has not been established. The aim of this study was to clarify the low potency of FOBT surveillance at short intervals after colonoscopy.
Methods: Colonoscopy was performed in 1308 average-risk patients, based on positive results of immunological FOBT [fecal immunological test (FIT)].
The role of faecal calprotectin in the identification of colorectal neoplasia in patients attending for screening colonoscopy.
Colorectal Dis
February 2022
Academic Unit of Surgery, School of Medicine, Glasgow Royal Infirmary, University of Glasgow, Glasgow, UK.
Aim: Although the relationship between colorectal neoplasia and inflammation is well described, the role of faecal calprotectin (FC) in clinical practice to diagnose or screen patients for colorectal neoplasia is less defined. This prospective study characterizes the relationship between FC and colorectal neoplasia in patients within the faecal occult blood testing (FOBT) positive patients in the Scottish Bowel Screening Programme.
Methods: All FOBT positive patients attending for colonoscopy between February 2016 and July 2017 were invited to participate.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!